Maple Ridge, Canada

Edward D Yaworski

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 605(Granted Patents)


Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Edward D. Yaworski: Innovator in Nucleic Acid Delivery Technologies

Introduction

Edward D. Yaworski is a prominent inventor based in Maple Ridge, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. With a total of 7 patents to his name, Yaworski's work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Among his latest patents, Yaworski has developed compositions and methods for delivering messenger RNA. This invention provides compositions comprising nucleic acid molecules, such as mRNA molecules, encapsulated within lipid particles. These compositions are useful for introducing mRNA molecules into a human subject, where they can be translated to produce a polypeptide that functions to ameliorate one or more symptoms of a disease. Another notable patent focuses on lipid formulations for nucleic acid delivery. This invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, along with methods for making and administering these lipid particles. More specifically, it includes stable nucleic acid-lipid particles (SNALP) that comprise a nucleic acid, such as one or more interfering RNA, along with methods for their production and delivery.

Career Highlights

Edward D. Yaworski has worked with several notable companies in the biotechnology sector. He has been associated with Protiva Biotherapeutics, Inc. and Arbutus Biopharma Corporation, where he has contributed to the advancement of biotherapeutic technologies. His expertise in nucleic acid delivery systems has positioned him as a key player in the field.

Collaborations

Yaworski has collaborated with several professionals in his field, including Kieu Lam and Lloyd B. Jeffs. These collaborations have further enhanced his research and development efforts in biotechnology.

Conclusion

Edward D. Yaworski's innovative work in nucleic acid delivery technologies showcases his commitment to advancing therapeutic solutions. His contributions are paving the way for new treatments that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…